This edition focuses on pharmaceutical sterile products. It includes insightful articles on the proposed changes to EudraLex Annex 1 relating to sterile products as well as a checklist of points to consider when auditing a terminally sterilized product. It also covers NSF’s latest news including the expansion of our Indian team to provide the world-class training and consultancy that is needed in this region.